VanEck Uranium & Nuclear ETF vs Tempus AI — how do they compare? VanEck Uranium & Nuclear ETF trades at $123.2, while Tempus AI trades at $61.15 (market cap $11.67B). Which is the better fit depends on your goals.
| NLR | TEM | |
|---|---|---|
Sector | Sector/Thematic | Broad Market / Factor |
52-Week High | $164.37 | $103.25 |
52-Week Low | $102.70 | $41.55 |
Market Cap | — | $11.67B |
Enterprise Value | — | $12.30B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Tempus AI (TEM) trades at $64.29, down 0.51% on the day, with a bullish technical signal and strong analyst support. The stock shows consistent earnings beats despite negative profitability, with a P/S of 7.99 and P/B of 26.23. Recent catalysts include FDA clearance for an AI ECG product and a $9.5 million ARPA-H award for autonomous AI in cardiology (Business Wire, September 9, 2026).
Outlook remains positive given analyst consensus and growth in precision medicine, but risks include sustained losses, high valuation multiples, and cash burn. The consensus price target is $69.11, implying potential upside, though investors must weigh the company's unprofitability against its innovation pipeline and market position.
Trailing returns across standard periods
VanEck Uranium and Nuclear ETF seeks exposure to companies involved in uranium mining and the nuclear power industry. Its holdings may include miners, utilities, reactor-related companies, and nuclear equipment or service providers.
Read more on NLR →Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →